Inclusion of radiobiological factors in prostate brachytherapy treatment planning

Courtney Knaup, Panayiotis Mavroidis, Gregory P Swanson, Sotirios Stathakis, Dimos Baltas, Nikos Papanikolaou

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Comparison of prostate seed implant treatment plans is currently based on evaluation of dose-volume histograms and doses to the tumour and normal structures. However, these do not account for effects of varying dose-rate, tumour repopulation and other biological effects. In this work, incorporation of the radiobiological response is used to obtain a more inclusive and clinically relevant treatment plan evaluation tool. Materials and Methods: Ten patients were evaluated. For each patient, six different treatment plans were created on the Prowess system. Plans with iodine-125 used a prescription dose of 145 Gy while plans with palladium-103 used 115 Gy. The biologically effective dose was used together with the tumour control probability and the normal tissue complication probabilities of urethra, bladder, rectum and surrounding tissue to evaluate the effectiveness of each treatment plan. Results from the radiobiological evaluation were compared to standard dose quantifiers. Results: The use of response probabilities is seen to provide a simpler means of treatment evaluation compared to standard dose quantifiers. This allows for different treatment plans to be quickly compared. Additionally, the use of radiobiologically-based plan evaluation allows for optimisation of seed type and initial seed strengths to find the ideal balance of TCP and NTCP. Conclusion: The goal of this work was to incorporate the biological response to obtain a more complete and clinically relevant treatment plan evaluation tool. This resulted in a simpler means of plan evaluation that may be used to compare and optimise prostate seed implant treatment plans.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalJournal of Radiotherapy in Practice
Volume12
Issue number2
DOIs
StatePublished - Jun 2013

Fingerprint

Brachytherapy
Prostate
Seeds
Therapeutics
Neoplasms
Palladium
Urethra
Rectum
Iodine
Prescriptions
Urinary Bladder

Keywords

  • Brachytherapy
  • Prostate
  • Radiobiology
  • Treatment Planning

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Oncology

Cite this

Inclusion of radiobiological factors in prostate brachytherapy treatment planning. / Knaup, Courtney; Mavroidis, Panayiotis; Swanson, Gregory P; Stathakis, Sotirios; Baltas, Dimos; Papanikolaou, Nikos.

In: Journal of Radiotherapy in Practice, Vol. 12, No. 2, 06.2013, p. 163-172.

Research output: Contribution to journalArticle

Knaup, Courtney ; Mavroidis, Panayiotis ; Swanson, Gregory P ; Stathakis, Sotirios ; Baltas, Dimos ; Papanikolaou, Nikos. / Inclusion of radiobiological factors in prostate brachytherapy treatment planning. In: Journal of Radiotherapy in Practice. 2013 ; Vol. 12, No. 2. pp. 163-172.
@article{00e4f393c4604ac48b22ac97665ed9ba,
title = "Inclusion of radiobiological factors in prostate brachytherapy treatment planning",
abstract = "Purpose: Comparison of prostate seed implant treatment plans is currently based on evaluation of dose-volume histograms and doses to the tumour and normal structures. However, these do not account for effects of varying dose-rate, tumour repopulation and other biological effects. In this work, incorporation of the radiobiological response is used to obtain a more inclusive and clinically relevant treatment plan evaluation tool. Materials and Methods: Ten patients were evaluated. For each patient, six different treatment plans were created on the Prowess system. Plans with iodine-125 used a prescription dose of 145 Gy while plans with palladium-103 used 115 Gy. The biologically effective dose was used together with the tumour control probability and the normal tissue complication probabilities of urethra, bladder, rectum and surrounding tissue to evaluate the effectiveness of each treatment plan. Results from the radiobiological evaluation were compared to standard dose quantifiers. Results: The use of response probabilities is seen to provide a simpler means of treatment evaluation compared to standard dose quantifiers. This allows for different treatment plans to be quickly compared. Additionally, the use of radiobiologically-based plan evaluation allows for optimisation of seed type and initial seed strengths to find the ideal balance of TCP and NTCP. Conclusion: The goal of this work was to incorporate the biological response to obtain a more complete and clinically relevant treatment plan evaluation tool. This resulted in a simpler means of plan evaluation that may be used to compare and optimise prostate seed implant treatment plans.",
keywords = "Brachytherapy, Prostate, Radiobiology, Treatment Planning",
author = "Courtney Knaup and Panayiotis Mavroidis and Swanson, {Gregory P} and Sotirios Stathakis and Dimos Baltas and Nikos Papanikolaou",
year = "2013",
month = "6",
doi = "10.1017/S1460396912000209",
language = "English (US)",
volume = "12",
pages = "163--172",
journal = "Journal of Radiotherapy in Practice",
issn = "1460-3969",
publisher = "Cambridge University Press",
number = "2",

}

TY - JOUR

T1 - Inclusion of radiobiological factors in prostate brachytherapy treatment planning

AU - Knaup, Courtney

AU - Mavroidis, Panayiotis

AU - Swanson, Gregory P

AU - Stathakis, Sotirios

AU - Baltas, Dimos

AU - Papanikolaou, Nikos

PY - 2013/6

Y1 - 2013/6

N2 - Purpose: Comparison of prostate seed implant treatment plans is currently based on evaluation of dose-volume histograms and doses to the tumour and normal structures. However, these do not account for effects of varying dose-rate, tumour repopulation and other biological effects. In this work, incorporation of the radiobiological response is used to obtain a more inclusive and clinically relevant treatment plan evaluation tool. Materials and Methods: Ten patients were evaluated. For each patient, six different treatment plans were created on the Prowess system. Plans with iodine-125 used a prescription dose of 145 Gy while plans with palladium-103 used 115 Gy. The biologically effective dose was used together with the tumour control probability and the normal tissue complication probabilities of urethra, bladder, rectum and surrounding tissue to evaluate the effectiveness of each treatment plan. Results from the radiobiological evaluation were compared to standard dose quantifiers. Results: The use of response probabilities is seen to provide a simpler means of treatment evaluation compared to standard dose quantifiers. This allows for different treatment plans to be quickly compared. Additionally, the use of radiobiologically-based plan evaluation allows for optimisation of seed type and initial seed strengths to find the ideal balance of TCP and NTCP. Conclusion: The goal of this work was to incorporate the biological response to obtain a more complete and clinically relevant treatment plan evaluation tool. This resulted in a simpler means of plan evaluation that may be used to compare and optimise prostate seed implant treatment plans.

AB - Purpose: Comparison of prostate seed implant treatment plans is currently based on evaluation of dose-volume histograms and doses to the tumour and normal structures. However, these do not account for effects of varying dose-rate, tumour repopulation and other biological effects. In this work, incorporation of the radiobiological response is used to obtain a more inclusive and clinically relevant treatment plan evaluation tool. Materials and Methods: Ten patients were evaluated. For each patient, six different treatment plans were created on the Prowess system. Plans with iodine-125 used a prescription dose of 145 Gy while plans with palladium-103 used 115 Gy. The biologically effective dose was used together with the tumour control probability and the normal tissue complication probabilities of urethra, bladder, rectum and surrounding tissue to evaluate the effectiveness of each treatment plan. Results from the radiobiological evaluation were compared to standard dose quantifiers. Results: The use of response probabilities is seen to provide a simpler means of treatment evaluation compared to standard dose quantifiers. This allows for different treatment plans to be quickly compared. Additionally, the use of radiobiologically-based plan evaluation allows for optimisation of seed type and initial seed strengths to find the ideal balance of TCP and NTCP. Conclusion: The goal of this work was to incorporate the biological response to obtain a more complete and clinically relevant treatment plan evaluation tool. This resulted in a simpler means of plan evaluation that may be used to compare and optimise prostate seed implant treatment plans.

KW - Brachytherapy

KW - Prostate

KW - Radiobiology

KW - Treatment Planning

UR - http://www.scopus.com/inward/record.url?scp=84879925350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879925350&partnerID=8YFLogxK

U2 - 10.1017/S1460396912000209

DO - 10.1017/S1460396912000209

M3 - Article

VL - 12

SP - 163

EP - 172

JO - Journal of Radiotherapy in Practice

JF - Journal of Radiotherapy in Practice

SN - 1460-3969

IS - 2

ER -